| Foreword to the fourth edition |
|
ix | |
| Preface to the fourth edition |
|
x | |
| Introduction |
|
xi | |
| Acknowledgements |
|
xii | |
|
Section One: Basic Pyschopharmacology |
|
|
1 | (62) |
|
Hypnotic and anxiolytic drugs |
|
|
3 | (8) |
|
|
|
3 | (2) |
|
|
|
5 | (1) |
|
|
|
6 | (1) |
|
|
|
7 | (4) |
|
|
|
7 | (1) |
|
|
|
7 | (1) |
|
|
|
8 | (1) |
|
|
|
8 | (1) |
|
|
|
9 | (1) |
|
|
|
9 | (1) |
|
|
|
10 | (1) |
|
|
|
11 | (19) |
|
|
|
11 | (1) |
|
Conventional antipsychotics |
|
|
12 | (5) |
|
|
|
12 | (2) |
|
|
|
14 | (1) |
|
|
|
15 | (1) |
|
|
|
15 | (1) |
|
|
|
16 | (1) |
|
|
|
16 | (1) |
|
|
|
17 | (10) |
|
|
|
17 | (2) |
|
|
|
19 | (2) |
|
|
|
21 | (1) |
|
|
|
22 | (1) |
|
|
|
23 | (1) |
|
|
|
24 | (2) |
|
|
|
26 | (1) |
|
Antipsychotic depot injections |
|
|
27 | (3) |
|
|
|
27 | (1) |
|
|
|
28 | (1) |
|
|
|
28 | (1) |
|
|
|
28 | (1) |
|
|
|
28 | (1) |
|
|
|
29 | (1) |
|
|
|
29 | (1) |
|
|
|
29 | (1) |
|
|
|
30 | (24) |
|
|
|
30 | (1) |
|
Tricyclic antidepressants (TCAs) |
|
|
31 | (5) |
|
|
|
31 | (2) |
|
|
|
33 | (1) |
|
|
|
33 | (1) |
|
|
|
34 | (1) |
|
|
|
34 | (1) |
|
|
|
34 | (1) |
|
|
|
35 | (1) |
|
Monoamine oxidase inhibitors (MAOIs) |
|
|
36 | (1) |
|
Reversible inhibitors of monoamine oxidase type A (RIMAs) |
|
|
37 | (1) |
|
Second-generation antidepressants |
|
|
38 | (2) |
|
|
|
38 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
Selective serotonin reuptake inhibitors (SSRIs) |
|
|
40 | (7) |
|
|
|
40 | (2) |
|
|
|
42 | (1) |
|
|
|
42 | (1) |
|
|
|
42 | (1) |
|
|
|
43 | (1) |
|
|
|
44 | (1) |
|
|
|
45 | (1) |
|
|
|
46 | (1) |
|
Serotonin and noradrenaline reuptake inhibitors (SNRIs) |
|
|
47 | (3) |
|
|
|
47 | (1) |
|
|
|
48 | (2) |
|
Noradrenergic and specific serotonergic antidepressants (NaSSAs) |
|
|
50 | (2) |
|
Noradrenaline reuptake inhibitors (NARIs) |
|
|
52 | (2) |
|
|
|
52 | (1) |
|
|
|
53 | (1) |
|
|
|
53 | (1) |
|
|
|
54 | (9) |
|
|
|
54 | (3) |
|
|
|
57 | (2) |
|
Sodium valproate/valproate semisodium |
|
|
59 | (4) |
|
Section Two: Applied Clinical Psychopharmacology |
|
|
63 | (82) |
|
Borderline personality disorder (BPD) |
|
|
65 | (2) |
|
|
|
67 | (2) |
|
Obsessive compulsive disorder (OCD) |
|
|
69 | (2) |
|
Post-traumatic stress disorder (PTSD) |
|
|
71 | (2) |
|
|
|
73 | (2) |
|
Generalised anxiety disorder (GAD) |
|
|
75 | (2) |
|
Dissociative (conversion) disorder |
|
|
77 | (2) |
|
Persistent delusional disorder |
|
|
79 | (2) |
|
Depression with panic attacks |
|
|
81 | (2) |
|
|
|
83 | (2) |
|
|
|
85 | (2) |
|
Depressive disorder in a patient with epilepsy |
|
|
87 | (2) |
|
Depressive disorder in a patient with cardiovascular disease |
|
|
89 | (2) |
|
|
|
91 | (2) |
|
|
|
93 | (2) |
|
Non-resistant bipolar affective disorder (mania) |
|
|
95 | (2) |
|
Resistant bipolar affective disorder (mania) |
|
|
97 | (2) |
|
Rapid-cycling bipolar affective disorder |
|
|
99 | (2) |
|
Antidepressant-induced switching to mania in bipolar affective disorder |
|
|
101 | (2) |
|
Bipolar affective disorder (depression) - bipolar depression |
|
|
103 | (2) |
|
Bipolar affective disorder (acute mania) in pregnancy |
|
|
105 | (2) |
|
Non-resistant schizophrenia |
|
|
107 | (2) |
|
|
|
109 | (2) |
|
Schizophrenia with negative symptoms |
|
|
111 | (2) |
|
Schizophreniform psychosis in a patient with epilepsy |
|
|
113 | (2) |
|
Schizophrenia in pregnancy |
|
|
115 | (2) |
|
Schizoaffective disorder (schizomania) |
|
|
117 | (2) |
|
|
|
119 | (4) |
|
Alzheimer's disease (mild to moderate) |
|
|
123 | (4) |
|
|
|
127 | (4) |
|
Acute alcohol withdrawal/alcohol dependence |
|
|
131 | (4) |
|
Acute opiate withdrawal/chronic opiate dependence |
|
|
135 | (2) |
|
Acute henzodiazepine withdrawal/chronic benzodiazepine dependence |
|
|
137 | (2) |
|
Self-injurious behaviour (SIB)/learning disability/temporal lobe epilepsy |
|
|
139 | (2) |
|
The acutely disturbed patient - rapid tranquillisation |
|
|
141 | (4) |
| Index |
|
145 | |
Daugiau apie elektronines knygas